References
- Wiese M, Pajeva IK. Structure-activity relationships of multidrug resistance reversers. Curr Med Chem 2001; 8 (6): 685–713.
- Krishna R, Mayer LD. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinet-ics of anticancer drugs. Eur J Pharm Sci 2000; 11 (4): 265–83.
- Ford JM. Experimental reversal of P-glycoprotein-medi-ated multidrug resistance by pharmacological chemosensitisers. Eur J Cancer 1996; 32A (6): 991–1001.
- Scambia G, Ranelletti FO, Panici PB et al. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol 1994; 34 (6): 459–64.
- Zhu A, Wang X, Guo Z. Study of tea polyphenol as a reversal agent for carcinoma cell lines' multidrug resistance (study of TP as a MDR reversal agent). Nucl Med Biol 2001; 28 (6): 735–40.
- Plouzek CA, Ciolino HP, Clarke R, Yeh GC. Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract. Eur J Cancer 1999; 35 (10): 1541–5.
- Ye CL, Lu YH, Wei DZ. Flavonoids from Cleistocalyx operculatus. Phytochemistry 2004; 65 (4): 445–7.
- Ye CL, Liu JW, Wei DZ, Lu YH, Qian F. In vitro anti-tumor activity of 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone against six established human cancer cell lines. Pharmacol Res 2004; 50 (5): 505–10.
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65 (1-2): 55–63.
- Dekker K, Kojima N, Yamamoto S, Tatsumi K, Mino M, Yagi K. A simple fluorometric method to discriminate adri-amycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line. Biochem Int 1987; 14 (6): 997–1001.
- Fu LW, Zhang YM, Liang YJ, Yang XP, Pan QC. The multidrug resistance of tumour cells was reversed by tetran-drine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Eur J Cancer 2002; 38 (3): 418–26.
- Dolci ED, Abramson R, Xuan Y et al. Anomalous expression of P-glycoprotein in highly drug-resistant human KB cells. Int J Cancer 1993; 54 (2): 302–8.
- Lehnert M. Chemotherapy resistance in breast cancer. Anticancer Res 1998; 18 (3C): 2225-6.
- Sharom FJ. The P-glycoprotein efflux pump: how does it transport drugs? J Membr Biol 1997; 160 (3): 161–75.
- Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharma-cological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999; 39: 361–98.
- Shapiro AB, Ling V. Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem Pharmacol 1997; 53 (4): 587–96.
- Jodoin J, Demeule M, Beliveau R. Inhibition of the mul-tidrug resistance P-glycoprotein activity by green tea polyphe-nols. Biochim Biophys Acta 2002; 1542 (1-3): 149–59.
- Castro AF, Altenberg GA. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycopro-tein. Biochem Pharmacol 1997; 53 (1): 89–93.
- Ikegawa T, Ushigome F, Koyabu N et al. Inhibition of P-glycoprotein by orange juice components, poly-methoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. Cancer Lett 2000; 160 (1): 21-8.
- Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 2002; 64 (4): 573–82.
- Choi CH, Sun KH, An CS et al. Reversal of P-glyco-protein-mediated multidrug resistance by 5,6,7,3',4'-pen-tamethoxyflavone (Sinensetin). Biochem Biophys Res Commun 2002; 295 (4): 832–40.